Recombinant Modified Vaccinia Virus Ankara Provides Durable Protection Against Disease Caused by an Immunodeficiency Virus as well as Long Term Immunity to an Orthopoxvirus in a Non-Human Primate

Recombinant and non-recombinant modified vaccinia virus Ankara (MVA) strains are currently in clinical trials as human immunodeficiency virus-1 (HIV) and attenuated smallpox vaccines, respectively. Here we tested the ability of a recombinant MVA delivered by alternative needle-free routes (intramusc...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Earl, Patricia L., Americo, Jeffrey L., Wyatt, Linda S., Eller, Leigh Anne, Montefiori, David C., Byrum, Russ, Piatak, Michael, Lifson, Jeffrey D., Amara, Rama Rao, Robinson, Harriet L., Huggins, John W., Moss, Bernard
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2007
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2077303/
https://ncbi.nlm.nih.gov/pubmed/17499326
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.virol.2007.02.041
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi